Invention Application
US20020156094A1 Sulfonamide interleukin-1beta converting enzyme inhibitors 审中-公开
磺酰胺白细胞介素-1β转换酶抑制剂

Sulfonamide interleukin-1beta converting enzyme inhibitors
Abstract:
The present invention relates to compounds that are inhibitors of interleukin-1null converting enzyme that have the Formula (I). This invention also relates to a method of treatment of stroke, reperfusion injury, Alzheimer's disease, shigellosis, inflammatory diseases, and septic shock and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1null converting enzyme.
Information query
Patent Agency Ranking
0/0